David-Alexandre C Gros
CIK 1644489 · Chief Executive Officer · last filed 2025-01-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$315.0K
Companies
4
Total Filings
16
Lifetime Open-Market Net
$120.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELDN | Chief Executive Officer | 9,000 | $3.57 | $32.1K | $57.8K | 9 | 2025-01-13 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Chief Executive Officer | — | — | — | $0 | 1 | 2020-09-15 |
| NBIX | President & COO | — | $159.76 | — | $0 | 2 | 2017-02-08 |
| ALNY | SVP, Chief Business Officer | 1,000 | $282.85 | $282.9K | $62.7K | 4 | 2016-12-22 |
Recent Filings · Page 2 of 2
16 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-02-08 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2017-02-02 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2016-12-22 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2016-02-24 | ALNY | Buy (P) | +1,000 | $62.7K | EDGAR |
| 2015-12-22 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2015-06-10 | ALNY | Grant (A) | — | $0 | EDGAR |
Showing 11–16 of 16
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.